|
Expression of GPAA1 (High vs Low)
|
0.735
|
0.530–1.019
|
0.045
|
|
Age (≥65 vs. < 65)
|
1.486
|
1.142–1.932
|
0.003
|
|
Gender (Male vs. Female)
|
0.871
|
0.662–1.147
|
0.326
|
|
TNM Stage (III-IV vs. I-II)
|
4.754
|
3.487–6.482
|
0.000
|
|
Tumor Size (≥4 cm vs. < 4 cm)
|
3.192
|
2.274–4.481
|
0.000
|
|
Pathology Grade (I, I-II, II vs. II-III, III)
|
1.288
|
0.961–1.725
|
0.090
|
|
Expression of ERBB2 (High vs Low)
|
1.137
|
0.855–1.511
|
0.003
|
|
Lymphatic metastasis (Present vs. Absent)
|
3.852
|
2.751–5.934
|
0.000
|
|
Distant metastasis (Present vs. Absent)
|
1.176
|
0.165–8.395
|
0.871
|
|
Vascular invasion (Present vs. Absent)
|
2.435
|
1.795–3.303
|
0.000
|
|
Perineuronal invasion (Present vs. Absent)
|
2.152
|
1.531–3.025
|
0.000
|
|
Histology (Poor vs. well & moderate)
|
0.833
|
0.638–1.807
|
0.179
|
